![Sudip Bandyopadhyay, Inditrade Capital-1200](https://img.etimg.com/thumb/msid-84823694,width-210,height-158,imgsize-105698,resizemode-75/sudip-bandyopadhyay-inditrade-capital-1200.jpg)
On the auto pack
The challenges are different in different buckets of four-wheelers. As far as Tata Motors is concerned, it is pretty well known that the company has declared that the chip shortage is going to affect the luxury vehicle production and that is across the board for all the luxury manufacturers. Tata Motors predominantly is dependent on JLR for its profitability and top line. So we will have to be careful about Tata Motors at this stage.
As far as Maruti is concerned, I will be a little cautious. The first quarter was a washout with significant challenges due to the lockdown. The second quarter has begun on a right note but there are multiple challenges ahead. Consumption has not yet picked up that much. There is competition in multiple segments including the SUVs where the sales numbers are picking up. Maruti is an excellent company but at this stage I am not recommending a buy.
Mahindra looks pretty good. Tractor sales are expected to be improving. Rural India has probably come out of the challenges of the second wave and rural consumption is again picking up. The FMCG numbers are demonstrating that and we believe on the back of the monsoon which has now recovered, tractor demands will keep moving up. So, Mahindra has a good runway ahead and at current level, Mahindra can be definitely bought by investors with a one-year time horizon and a target of around Rs 1,000.
On the pharmaceutical pack
I will also look at API focussed companies which has good prospects going forward. Granules can be looked at even at current levels also. Also, some of the interesting pharma names which are planning to come out with IPOs can be looked at. One company which did an IPO and moved up quite a bit is Gland Pharma. It can still move up from current level. The business is solid and you know their track record as far as the regulatory compliance have been exemplary. So, Gland is a definite bet.
On corporate and the PSU banks
I had a bit of a concern regarding the valuations at which HDFC Bank and Kotak Mahindra Bank were quoting for some time. These are fantastic banks with a great balance sheet but at some stage, PE multiples are given for growth and if the growth is not happening in the loan book, how long will those PE multiples be allowed by the market was the question and that is the reason why these banks are showing a bit of a sell off.
Having said that, fundamentally there is nothing wrong. It is just that the loan books need to grow at a much faster pace for both HDFC and Kotak to keep pace with the multiples which they have been given by the market. As far as ICICI and IndusInd are concerned, it is exactly the opposite. They have started growing aggressively. The economy is opening up and showing signs of demand for private capex after a long time. There is demand for money from the banks and the banks which keep pace with that demand in a controlled and calibrated manner will definitely be rewarded.
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price